Quidel | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Abbott USD 1.91B 41M 2024-12
Agilent USD 376M 32M 2025-01
Avanos Medical USD -418500000 430.5M 2024-12
Becton, Dickinson and Co. USD 453M 195M 2024-12
Bruker USD 64.1M 4M 2024-12
Charles River Laboratories USD -167687000 285.09M 2024-12
Danaher USD 1.42B 467M 2024-12
Exact Sciences USD -876351000 836.95M 2024-12
Haemonetics USD 59.03M 7.33M 2024-12
Hologic USD 229.8M 200K 2024-12
Illumina USD 175M 566M 2024-12
IQVIA Holdings USD 626M 76M 2024-12
Merit Medical Systems USD 36.56M 697K 2024-12
Mettler Toledo International USD 314.55M 295.95M 2024-12
Myriad Genetics USD -39000000 19M 2024-12
Neogen USD 5.42M 462.9M 2025-02
Quidel USD -100400000 115.4M 2024-12
Revvity USD 118.75M 20.6M 2024-12
STAAR Surgical USD -27910000 33.59M 2024-12
Thermo Fisher Scientific USD 2.02B 178M 2024-12
Waters USD 292.26M 81.13M 2024-12



Quidel Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.